Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02137473
Other study ID # 1000044263
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 2014
Est. completion date March 2016

Study information

Verified date November 2021
Source The Hospital for Sick Children
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Most very low birth weight infants accumulate a nutrient deficit in hospital due to minimal nutrient reserves and elevated nutritional requirements which may contribute to poor outcome. Adding nutrients to human milk improves their nutritional status and growth, but it is unclear if adding bovine protein-based fortifiers as is the current standard of care has some unintended negative consequences to neonates. Infants will be randomized to have their feeds (mother's own milk or pasteurized donor breastmilk) nutrient enriched with a human milk-based fortifier or a bovine protein-based fortifier and will be followed in hospital to assess feeding tolerance, growth, gut inflammation, mother's milk and infant gut microbiome, and neonatal morbidity and mortality.


Recruitment information / eligibility

Status Completed
Enrollment 127
Est. completion date March 2016
Est. primary completion date January 2016
Accepts healthy volunteers
Gender All
Age group N/A to 2 Weeks
Eligibility Inclusion Criteria: - <1250g birth weight - Parent(s) or guardian(s) agree to use donor breastmilk if own mother's milk supply is insufficient Exclusion Criteria: - Infant receives formula or a nutrient fortifier prior to randomization - >day 14 at the time of enrollment and enteral feeds have not commenced - Infants with major congenital or chromosomal anomalies that could impact growth - Enrollment in another research study affecting nutritional management during the feeding intervention - Reasonable potential that the infant will be transferred to a neonatal intensive care unit where the study protocol will not be continued

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Human milk-based fortifier

Bovine protein-based fortifier


Locations

Country Name City State
Canada William Osler Health System-Brampton Brampton Ontario
Canada William Osler Health System-Etobicoke Etobicoke Ontario
Canada Izaak Walton Killam Health Centre Halifax Nova Scotia
Canada Markham Stouffville Hospital Markham Ontario
Canada Southlake Regional Health Centre Newmarket Ontario
Canada Lakeridge Health Oshawa Ontario
Canada Mackenzie Health Richmond Hill Ontario
Canada Humber River Hospital Toronto Ontario
Canada Mount Sinai Hospital Toronto Ontario
Canada North York General Hospital Toronto Ontario
Canada Rouge Valley Health System Toronto Ontario
Canada St Joseph's Health Centre Toronto Ontario
Canada St Michael's Hospital Toronto Ontario
Canada Sunnybrook Health Sciences Centre Toronto Ontario
Canada The Hospital for Sick Children Toronto Ontario
Canada The Scarborough Hospital-Birchmount Toronto Ontario
Canada The Scarborough Hospital-General Toronto Ontario
Canada Toronto East General Hospital Toronto Ontario

Sponsors (1)

Lead Sponsor Collaborator
The Hospital for Sick Children

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Other Other measures of feeding tolerance Percent and number of days of emesis, gastric aspirates >50% pre-feed volume, abdominal distension (>2 cm), percentage of infants where enteral feeding was terminated and parenteral nutrition had to be commenced, some assessment of the interruption of feeds, how long it takes to reach full enteral feeds (150 ml/kg/d) 84 days of age, hospital discharge or when able to consume two oral feeds a day without supplementation (e.g. tube feeding), whichever comes first
Other Gut inflammation 84 days of age, hospital discharge or when able to consume two oral feeds a day without supplementation (e.g. tube feeding), whichever comes first
Other Morbidity/mortality composite Necrotizing enterocolitis, late onset sepsis, chronic lung disease, severe retinopathy of prematurity, death 84 days of age, hospital discharge or when able to consume two oral feeds a day without supplementation (e.g. tube feeding), whichever comes first
Other Bayley Scales of Infant and Toddler Development (BSID)-III Cognitive, language and motor development as assessed by the BSID-III 18-24 months corrected age
Other Gut microbiota 56 days of age or hospital discharge
Primary Feeding tolerance Percentage of infants with a significant feeding interruption as defined by days feedings held for =12 hours OR feeds reduced by >50% (ml/kg/d) not due to a clinical procedure or transitioning to the breast 84 days of age, hospital discharge or when able to consume two oral feeds a day without supplementation (e.g. tube feeding), whichever comes first
Secondary Growth Daily weight measurements, weekly length measurements, weekly head circumference measurements, z-scores for anthropometric measures 84 days of age, hospital discharge or when able to consume two oral feeds a day without supplementation (e.g. tube feeding), whichever comes first